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MissedHeterozygous Deletion in Study
of Next-Generation Sequencing forMolecular
Diagnosis in PatientsWith Infantile
Nystagmus Syndrome
TotheEditor Inourarticle“AccuracyofNext-GenerationSequenc-
ingforMolecularDiagnosis inPatientsWithInfantileNystagmus
Syndrome,”1we originally reported that patient 8 had a homo-
zygousmutation(c.709C>T)inNMNAT1.Thepatient’sfatherwas
aheterozygouscarrierforthec.709C>Tmutation,butthemother
wasnot.Wesuspectedthatthiscouldbefromuniparentaldisomy
ormaternalmosaicism.After furtheranalysisusingourcustom-
ized algorithm to detect copynumber variation,wenoted that
wemissedaheterozygousdeletionofexons4and5(Figure).Be-
cause thec.709C>Tmutationwas located in thedeletedregion,
we could confirm the pseudohomozygosity and conclude that
the patient had compound heterozygosity for hemizygous
c.709C>T andheterozygous deletion of exons 4 and 5. The de-
letionofexons4and5inNMNAT1wasinheritedfromthemother.
This change affects 1 row and 1 footnote in Table 2 of our
article.1 A new reference has been added to the References list
and is cited inTable2.1 These changesdonot affect our conclu-
sions.Wehaverequestedcorrectiontothearticletoaddressthese
errors.2Weconfirmtherearenoothererrors in thepublishedar-
ticle. Table 2 has been corrected online.
Figure. A Heterozygous Deletion of Exons 4 and 5Was Detected Using the ExomeDepth and Customized Depth Normalizing Software
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Diffuse UvealMelanocytic Proliferation
With Primary Vitreoretinal Lymphoma
To the Editor We congratulate Leskov et al on their excellent
imaging documentation1 of a unilateral case of primary vit-
reoretinal lymphoma.Theauthorsnotedagiraffe skin–like ap-
pearance of the right funduswith apparent areas of hyperpig-
mentation and corresponding hypoautofluorescence that
resembles the retinal pigment epithelial (RPE) alterations of
bilateral diffuse uveal melanocytic proliferation (BDUMP).
Characteristic features of BDUMP include bilateralmulti-
focal red subretinal patches at the level of the RPE that re-
semble a giraffe skin, early hyperfluorescence on fluorescein
angiography, and diffuse melanocytic infiltration of the
choroid.1 Naysan et al2 reported multimodal imaging fea-
tures of BDUMP and demonstrated classic optical coherence
tomographic findings of RPE thickening and losswith choroi-
dal infiltration and thickening.
Leskovetal1 foundareasofRPEthickeningandthinningon
optical coherence tomography,but the findingswereunilateral,
and theauthors specifically stated thatneither eyehadchoroi-
dal thickening.Thehistopathology imageshowedatypical lym-
phocytes withoutmelanocytic proliferation. Given the unilat-
erality, lackofchoroidal thickening,andabsenceofmelanocytic
proliferation, the findings in this case are not consistentwith a
diagnosisofBDUMPbutratherRPEalterationsanddetachments,
whicharecommonlyseen ineyeswithvitreoretinal lymphoma.
Themacularappearanceissuggestiveofaconditioncalledcloudy
vitelliformsubmaculopathy,whichhaspreviouslybeendescribed
in associationwith vitreoretinal lymphoma.3
Pefkianaki et al4 have also described BDUMP-like fundus
changeswithRPEalterations anddetachments as thepresent-
ingsignofcentralnervoussystemlymphoma,butwithoutcho-
roidal findings.Theauthors1notedchoroidal thickening to458
μm by optical coherence tomography without reporting the
choroidal thickness of the fellow eye, and a review of the op-
tical coherence tomographic images revealsRPEchangeswith-
out obvious choroidal infiltration. Huang5 has also reported
BDUMP-like fundus changes in a patientwith testicular T-cell
lymphomawith ocular involvement after treatmentwith sys-
temic chemotherapy, whole-body radiation, and intravitreal
methotrexate. This report5 described areas of RPE alterations
andatrophy resemblingBDUMP,without any choroidal thick-
ening or melanocytic proliferation. These authors1 have
recognized the classic features of vitreoretinal or testicular
lymphomawith RPE detachments and alterations and unfor-
tunatelymislabeled them as BDUMP. To fulfill the criteria for
BDUMP, documented choroidal infiltrationwithmelanocytic
proliferation should be observed.
Werecentlyreviewed168eyesof95patientswithvitreoreti-
nal lymphomaseenontheOcularOncologyServiceatWillsEye
HospitalandfoundextensiveRPEchanges in17%ofpatients.We
believethat thepseudo-BDUMPfundusappearancereportedby
Leskovetal1 is associatedwithalterationsat the levelof theRPE
and should be differentiated from true BDUMP.
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In ReplyDalvin andcolleagues state that the findings in thepa-
tientwe treated1whohadvitreoretinal lymphomaarenot con-
sistent with a diagnosis of diffuse uveal melanocytic prolif-
eration (DUMP). They base this on (1) the absence of
documented choroidal thickening, (2) the absenceofmelano-
cytic cells in the biopsy, and (3) the unilaterality or asymme-
try of the condition.
In the original article by Gass et al2 defining this condi-
tion, the first criterion was the presence of red patches at the
level of pigment epitheliumand intensehyperfluorescenceon
fluorescein angiography (termed giraffe skin). Both findings
were prominent in the case we reported.1 Gass et al2 pointed
out that this change can be seen prior to the detection of cho-
roidal thickening or melanocytic tumors. They did not have
optical coherence tomography.
In the original report,1 we stated that the choroid was not
thickened. In rereviewing the optical coherence tomographic
data,we found that it is clear that, at presentation, the choroid
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